Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$187.97
-1.3%
$168.62
$141.74
$283.00
$13.80B1.68913,292 shs79,850 shs
Alere Inc. stock logo
ALR
Alere
$1.32
$0.00
$34.41
$51.00
$43.05M0.8540,839 shsN/A
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$79.74
-2.5%
$80.22
$69.81
$112.38
$15.95B1.081.84 million shs382,756 shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$210.27
-2.6%
$215.99
$187.43
$358.22
$15.11B1.14960,481 shs65,946 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
+0.75%+9.92%+16.01%-7.27%-30.18%
Alere Inc. stock logo
ALR
Alere
0.00%0.00%0.00%0.00%0.00%
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
-3.17%+1.48%+5.55%-11.13%-11.93%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
-1.55%+5.04%+2.40%-33.20%-39.75%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Align Technology, Inc. stock logo
ALGN
Align Technology
4.8068 of 5 stars
4.35.00.03.82.91.71.3
Alere Inc. stock logo
ALR
Alere
N/AN/AN/AN/AN/AN/AN/AN/A
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
3.2518 of 5 stars
4.43.00.00.02.90.01.3
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.7243 of 5 stars
3.54.01.73.22.91.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Align Technology, Inc. stock logo
ALGN
Align Technology
2.67
Moderate Buy$241.2528.35% Upside
Alere Inc. stock logo
ALR
Alere
0.00
N/AN/AN/A
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
2.70
Moderate Buy$110.2538.26% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
3.00
Buy$332.5058.13% Upside

Current Analyst Ratings Breakdown

Latest ALR, COO, WST, and ALGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$255.00 ➝ $246.00
5/1/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$235.00 ➝ $250.00
5/1/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$165.00 ➝ $200.00
5/1/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/29/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$250.00 ➝ $245.00
4/25/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/25/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$290.00 ➝ $170.00
4/24/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$240.00 ➝ $215.00
4/21/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/25/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$295.00 ➝ $250.00
3/18/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$270.00 ➝ $235.00
(Data available from 5/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Align Technology, Inc. stock logo
ALGN
Align Technology
$3.98B3.46$9.76 per share19.26$51.60 per share3.64
Alere Inc. stock logo
ALR
Alere
$934.59M0.05N/AN/A$5.72 per share0.23
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$3.93B4.06$5.02 per share15.87$40.50 per share1.97
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.90B5.22$9.30 per share22.60$37.10 per share5.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Align Technology, Inc. stock logo
ALGN
Align Technology
$421.36M$5.4933.6021.002.2410.54%13.84%8.51%7/23/2025 (Estimated)
Alere Inc. stock logo
ALR
Alere
-$29.92M-$1.20N/AN/AN/A-5.34%-20.78%-9.02%N/A
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$392.30M$2.0640.9117.922.2510.07%9.38%6.09%5/29/2025 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$492.70M$6.3731.4326.756.7417.03%18.60%13.80%7/24/2025 (Estimated)

Latest ALR, COO, WST, and ALGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/29/2025Q2 2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$0.93N/AN/AN/A$995.12 millionN/A
4/30/2025Q1 2025
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.00$2.13+$0.13$1.27$977.90 million$979.26 million
4/24/2025Q1 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.22$1.45+$0.23$1.23$685.24 million$698.00 million
3/6/2025Q1 2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$0.92$0.92N/A$0.52$981.25 million$964.70 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
Alere Inc. stock logo
ALR
Alere
N/AN/AN/AN/AN/A
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
N/AN/AN/AN/AN/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.840.40%-4.48%13.19%N/A

Latest ALR, COO, WST, and ALGN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.210.39%7/30/20257/30/20258/6/2025
2/20/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.210.41%4/30/20254/30/20255/7/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.22
1.10
Alere Inc. stock logo
ALR
Alere
0.45
1.58
1.58
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
0.32
1.91
1.12
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.08
2.79
2.23

Institutional Ownership

CompanyInstitutional Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
Alere Inc. stock logo
ALR
Alere
24.08%
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
24.39%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
0.66%
Alere Inc. stock logo
ALR
Alere
8.40%
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
1.98%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.53%
CompanyEmployeesShares OutstandingFree FloatOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
23,20073.21 million74.19 millionOptionable
Alere Inc. stock logo
ALR
Alere
10,40032.61 million29.87 millionOptionable
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
14,000199.98 million195.59 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,70071.85 million71.92 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Align Technology stock logo

Align Technology NASDAQ:ALGN

$187.96 -2.46 (-1.29%)
As of 10:50 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Alere stock logo

Alere NYSE:ALR

Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.

Cooper Companies stock logo

Cooper Companies NASDAQ:COO

$79.74 -2.02 (-2.47%)
As of 10:50 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$210.26 -5.61 (-2.60%)
As of 10:49 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.